Brief Report: Severe Pneumonitis After Combined Thoracic Radiotherapy and Osimertinib

INTRODUCTION: Osimertinib is an effective treatment for metastatic NSCLC. Occasionally, thoracic radiation therapy (TRT) is delivered to patients receiving osimertinib to treat residual or progressing pulmonary tumors. Anecdotal reports suggest that the delivery of TRT in combination with osimertini...

Descripción completa

Detalles Bibliográficos
Autores principales: Smith, Clayton P., Xiang, Michael, Yoon, Stephanie M., Lee, Alan, Ruan, Dan, Goldman, Jonathan W., Cummings, Amy L., Lisberg, Aaron, Garon, Edward B., Moghanaki, Drew
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10009282/
https://www.ncbi.nlm.nih.gov/pubmed/36923158
http://dx.doi.org/10.1016/j.jtocrr.2023.100468

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10009282/
https://www.ncbi.nlm.nih.gov/pubmed/36923158
http://dx.doi.org/10.1016/j.jtocrr.2023.100468

Ejemplares similares